In this briefing, Peter Bach discusses the need to find a balance between the cost of prescription drugs and incentives for innovation in the pharmaceutical industry. 

In this essay, Dr. Peter Shin presents highlights from his study of how community health centers are faring post-ACA, including the challenges of operating in states that chose not to expand Medicaid coverage. Shin also notes that critical federal funding could be in jeopardy after 2017 unless Congress takes action.

This essay takes a look at developments in the small group market since the passage of the ACA and highlights several issues that could threaten the long-term viability of this market as implementation moves forward.

In this essay, Miriam Laugesen peeks behind the scenes at the process used to develop work-value recommendations, assessing the accuracy of the RUC’s time estimates, noting flaws in the specialty society survey process, and highlighting ways to introduce greater precision and transparency to the task.